Literature DB >> 29502158

Mitochondrial mRNA expression in fibroblasts of Down syndrome subjects.

Michele Salemi1, Mariaconcetta Giambirtone2, Concetta Barone2, Maria Grazia Salluzzo2, Roberto Russo2, Mariangela Lo Giudice2, Salvatore Cutuli2, Federico Ridolfo3, Corrado Romano2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29502158     DOI： 10.1007/s13577-018-0205-2

Source DB:  PubMed          Journal:  Hum Cell        ISSN： 0914-7470            Impact factor:   4.174


× No keyword cloud information.
  11 in total

Review 1.  Mitochondria, oxidative stress and neurodegeneration.

Authors:  Antonio Federico; Elena Cardaioli; Paola Da Pozzo; Patrizia Formichi; Gian Nicola Gallus; Elena Radi
Journal:  J Neurol Sci       Date:  2012-06-04       Impact factor: 3.181

Review 2.  Down's syndrome.

Authors:  Nancy J Roizen; David Patterson
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

3.  Differential display reveals deteriorated mRNA levels of NADH3 (complex I) in cerebellum of patients with Down syndrome.

Authors:  K Krapfenbauer; B C Yoo; N Cairns; G Lubec
Journal:  J Neural Transm Suppl       Date:  1999

4.  Electron transport chain defects in Alzheimer's disease brain.

Authors:  W D Parker; J Parks; C M Filley; B K Kleinschmidt-DeMasters
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

5.  Adaptive downregulation of mitochondrial function in down syndrome.

Authors:  Pablo Helguera; Jaqueline Seiglie; Jose Rodriguez; Michael Hanna; Gustavo Helguera; Jorge Busciglio
Journal:  Cell Metab       Date:  2013-01-08       Impact factor: 27.287

6.  Clinical features and diagnostic criteria of depression in Down's syndrome.

Authors:  S A Cooper; R A Collacott
Journal:  Br J Psychiatry       Date:  1994-09       Impact factor: 9.319

7.  Mitochondrial respiratory chain inhibitors induce apoptosis.

Authors:  E J Wolvetang; K L Johnson; K Krauer; S J Ralph; A W Linnane
Journal:  FEBS Lett       Date:  1994-02-14       Impact factor: 4.124

8.  Killer-specific secretory (Ksp37) gene expression in subjects with Down's syndrome.

Authors:  Michele Salemi; Concetta Barone; Maria Concetta Morale; Salvatore Caniglia; Carmelo Romano; Maria Grazia Salluzzo; Rosanna G Galati Rando; Alda Ragalmuto; Paolo Bosco; Corrado Romano
Journal:  Neurol Sci       Date:  2016-03-31       Impact factor: 3.307

9.  RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.

Authors:  Helen Wong; Josien Levenga; Peter Cain; Beverly Rothermel; Eric Klann; Charles Hoeffer
Journal:  Acta Neuropathol       Date:  2015-10-24       Impact factor: 17.088

10.  Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway.

Authors:  Daniela Valenti; Gabriella Arcangela Manente; Laura Moro; Ersilia Marra; Rosa Anna Vacca
Journal:  Biochem J       Date:  2011-05-01       Impact factor: 3.857
View more
  3 in total

1.  Trisomy 21 results in modest impacts on mitochondrial function and central carbon metabolism.

Authors:  Colin C Anderson; John O Marentette; Kendra M Prutton; Abhishek K Rauniyar; Julie A Reisz; Angelo D'Alessandro; Kenneth N Maclean; Laura M Saba; James R Roede
Journal:  Free Radic Biol Med       Date:  2021-06-12       Impact factor: 8.101

Review 2.  Above the Epitranscriptome: RNA Modifications and Stem Cell Identity.

Authors:  Francesco Morena; Chiara Argentati; Martina Bazzucchi; Carla Emiliani; Sabata Martino
Journal:  Genes (Basel)       Date:  2018-06-28       Impact factor: 4.096

3.  Humanin gene expression in fibroblast of Down syndrome subjects.

Authors:  Michele Salemi; Federico Ridolfo; Maria Grazia Salluzzo; Rossella Cannarrella; Mariaconcetta Giambirtone; Salvatore Caniglia; Cataldo Tirolo; Raffaele Ferri; Corrado Romano
Journal:  Int J Med Sci       Date:  2020-01-18       Impact factor: 3.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.